Jonathan Tegge - 16 Dec 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Interim CFO
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Jonathan Tegge
Issuer symbol
INM
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 16:04:34 UTC
Previous filing
15 Dec 2022
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +1,400 $0.000000 1,400 16 Dec 2022 Common shares 1,400 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting 1/12 per month, in arrears, for 12 months.